In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery.

[1]  Howard I. Maibach,et al.  Evaluation of the Barrier Function of Skin Using Transepidermal Water Loss (TEWL): A Critical Overview , 2014 .

[2]  N. Sarisuta,et al.  Chemical stability and mechanism of degradation of omeprazole in solutio , 2010 .

[3]  Y. Zambito,et al.  Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. , 2008, Journal of pharmaceutical sciences.

[4]  K. Järvinen,et al.  In vitro toxicity and permeation of cyclodextrins in Calu-3 cells. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[5]  F. Veiga,et al.  Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  A. Pais,et al.  Interaction of Omeprazole with a Methylated Derivative of β-Cyclodextrin: Phase Solubility, NMR Spectroscopy and Molecular Simulation , 2007, Pharmaceutical Research.

[7]  A. Bandyopadhyay,et al.  Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[8]  R. Guy,et al.  Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue. , 2005, Journal of pharmaceutical sciences.

[9]  P. Sharma,et al.  In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. , 2005, Farmaco.

[10]  A. Bernkop‐Schnürch,et al.  In Vitro Evaluation of Various Buccal Permeation Enhancing Systems for PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) , 2005, Pharmaceutical Research.

[11]  A. Bernkop‐Schnürch,et al.  Development of a mucoadhesive and permeation enhancing buccal delivery system for PACAP (pituitary adenylate cyclase-activating polypeptide). , 2005, International journal of pharmaceutics.

[12]  C. Leopold,et al.  Degradation of Omeprazole Induced by Enteric Polymer Solutions and Aqueous Dispersions: HPLC Investigations , 2005, Drug development and industrial pharmacy.

[13]  M. Brewster,et al.  Role of cyclodextrins in improving oral drug delivery , 2004 .

[14]  J. Nicolazzo,et al.  The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa. , 2003, Journal of pharmaceutical sciences.

[15]  T. Andersson,et al.  Omeprazole Disposition in Children following Single‐Dose Administration , 2003, Journal of clinical pharmacology.

[16]  J. Remon,et al.  Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol 974 P on rabbit nasal mucosa and slug mucosa. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Atilla Abidin or A. Hincal,et al.  Drug permeation enhancement via buccal route: possibilities and limitations. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[18]  M. Moreno,et al.  Comparison of derivative spectrophotometric and liquid chromatographic methods for the determination of omeprazole in aqueous solutions during stability studies. , 1999, Journal of pharmaceutical and biomedical analysis.

[19]  G. Másson,et al.  Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[20]  C. Cullander,et al.  Buccal mucosa in vitro experiments. I. Confocal imaging of vital staining and MTT assays for the determination of tissue viability. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[21]  K. Röhss,et al.  Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients. , 1997, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[22]  Roger A. Rajewski,et al.  Cyclodextrins: Their Future in Drug Formulation and Delivery , 1997, Pharmaceutical Research.

[23]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.

[24]  H. Boddé,et al.  Methods for assessing the buccal mucosa as a route of drug delivery , 1993 .

[25]  P. Wertz,et al.  Regional variation in the structure and permeability of oral mucosa and skin , 1993 .

[26]  P. Wertz,et al.  Permeability and the pathophysiology of oral mucosa , 1993 .

[27]  K. Uekama,et al.  Enhancing effects of cyclodextrins on nasal absorption of insulin in rats , 1992 .

[28]  R. Bergstrand,et al.  Influence of acid secretory status on absorption of omeprazole from enteric coated granules. , 1991, British journal of clinical pharmacology.

[29]  J. Cook,et al.  Viability measurements in mammalian cell systems. , 1989, Analytical biochemistry.

[30]  F. Hetrick,et al.  Mitochondrial damage and inhibition of respiration in animal cell cultures treated with Triton WR‐1339 , 1969, Journal of cellular physiology.

[31]  E. Cook.  The United States pharmacopoeia , 1945 .

[32]  J. Gaub.  The United States Pharmacopoeia , 1931, Science.

[33]  N. A. Epshtein.  STRUCTURE OF CHEMICAL COMPOUNDS , METHODS OF ANALYSIS AND PROCESS CONTROL VALIDATION OF HPLC TECHNIQUES FOR PHARMACEUTICAL ANALYSIS , 2004 .

[34]  A. Shojaei.  Buccal mucosa as a route for systemic drug delivery: a review. , 1998, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[35]  V. D. Gupta,et al.  Stability of Omeprazole Solutions at Various ph Values as Determined by High-Performance Liquid Chromatography , 1995 .

[36]  H E Junginger,et al.  Developments in buccal drug delivery. , 1991, Critical reviews in therapeutic drug carrier systems.

[37]  C. Goodman.  United States Pharmacopeial Convention , 1988 .

[38]  P. Wertz,et al.  The lipid composition of porcine epidermis and oral epithelium. , 1986, Archives of oral biology.

[39]  A. Mikos,et al.  Systems for controlled release of drugs. V. Bioadhesive systems , 1986 .